Early events in chikungunya virus infection—from virus cell binding to membrane fusion

Viruses

Volumn 7, Issue 7, 2015, Pages 3647-3674

  van Duijl Richter, Mareike K S ^a   Hoornweg, Tabitha E ^a   Rodenhuis Zybert, Izabela A ^a   Smit, Jolanda M ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Alphavirus; Cell tropism; Chikungunya virus; Clathrin; Endocytosis; Entry; Entry inhibitors; Fusion; Neutralizing antibodies; Receptor

Indexed keywords

CHAPERONIN 60; GLYCOSAMINOGLYCAN; PHOSPHATIDYLSERINE; PROHIBITIN; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; VIRUS RECEPTOR;

CELL INFILTRATION; CELL PROLIFERATION; CELL SURVIVAL; CELLULAR PARAMETERS; CHIKUNGUNYA; CHIKUNGUNYA VIRUS; DISEASE ASSOCIATION; ENDOCYTOSIS; LIFE CYCLE STAGE; MEMBRANE FUSION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN STABILITY; REVIEW; SIGNAL TRANSDUCTION; STRUCTURAL BIOINFORMATICS; VIRAL TROPISM; VIREMIA; VIRUS ATTACHMENT; VIRUS ENTRY; VIRUS INTERFERENCE; VIRUS REPLICATION; ANIMAL; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY; VIROLOGY;

ALPHAVIRUS; CHIKUNGUNYA VIRUS;

ANIMALS; CHIKUNGUNYA FEVER; CHIKUNGUNYA VIRUS; HUMANS; MEMBRANE FUSION; RECEPTORS, VIRUS; VIRUS ATTACHMENT; VIRUS INTERNALIZATION;

EID: 84936947996     PISSN: None     EISSN: 19994915     Source Type: Journal    
DOI: 10.3390/v7072792     Document Type: Review

References (188)

1. Thiberville, S.D.; Moyen, N.; Dupuis-Maguiraga, L.; Nougairede, A.; Gould, E.A.; Roques, P.; de Lamballerie, X. Chikungunya Fever: Epidemiology, Clinical Syndrome, Pathogenesis and Therapy. Antiviral Res. 2013, 99, 345–370.
2. Morrison, T.E. Reemergence of Chikungunya Virus. J. Virol. 2014, 88, 11644–11647.
3. Dupuis-Maguiraga, L.; Noret, M.; Brun, S.; Le Grand, R.; Gras, G.; Roques, P. Chikungunya Disease: Infection-Associated Markers from the Acute to the Chronic Phase of Arbovirus-Induced Arthralgia. PLoS Negl. Trop. Dis. 2012, 6, e1446.
4. Das, T.; Jaffar-Bandjee, M.C.; Hoarau, J.J.; Krejbich Trotot, P.; Denizot, M.; Lee-Pat-Yuen, G.; Sahoo, R.; Guiraud, P.; Ramful, D.; Robin, S.; et al. Chikungunya Fever: CNS Infection and Pathologies of a Re-Emerging Arbovirus. Prog. Neurobiol. 2010, 91, 121–129.
5. Pellot, A.S.; Alessandri, J.L.; Robin, S.; Samperiz, S.; Attali, T.; Brayer, C.; Pasquet, M.; Jaffar-Bandjee, M.C.; Benhamou, L.S.; Tiran-Rajaofera, I.; et al. Severe Forms of Chikungunya Virus Infection in a Pediatric Intensive Care Unit on Reunion Island. Med. Trop. (Mars) 2012, 72, 88–93.
6. Staples, J.E.; Breiman, R.F.; Powers, A.M. Chikungunya Fever: An Epidemiological Review of a Re-Emerging Infectious Disease. Clin. Infect. Dis. 2009, 49, 942–948.
7. Weaver, S.C.; Lecuit, M. Chikungunya Virus and the Global Spread of a Mosquito-Borne Disease. N. Engl. J. Med. 2015, 372, 1231–1239.
8. Pan American Health Organization. Number of Reported Cases of Chikungunya Fever in the Americas, by Country Or Territory 2013–2015 (to Week Noted) Epidemiological Week/EW 17. (Updated as of 1 May 2015)Available online: https://clinicaltri-als.gov/ct2/show/NCT02230163?term=Chikungunya&rank=5 or http://www. webcita-tion.org/6YE7aebST. (accessed on 2 May 2015).
9. Volk, S.M.; Chen, R.; Tsetsarkin, K.A.; Adams, A.P.; Garcia, T.I.; Sall, A.A.; Nasar, F.; Schuh, A.J.; Holmes, E.C.; Higgs, S.; et al. Genome-Scale Phylogenetic Analyses of Chikungunya Virus Reveal Independent Emergences of Recent Epidemics and various Evolutionary Rates. J. Virol. 2010, 84, 6497–6504.
10. Weaver, S.C.; Forrester, N.L. Chikungunya: Evolutionary History and Recent Epidemic Spread. Antiviral Res. 2015, 120, 32–39.
11. Tsetsarkin, K.A.; Chen, R.; Yun, R.; Rossi, S.L.; Plante, K.S.; Guerbois, M.; Forrester, N.; Perng, G.C.; Sreekumar, E.; Leal, G.; et al. Multi-Peaked Adaptive Landscape for Chikungunya Virus Evolution Predicts Continued Fitness Optimization in Aedes Albopictus Mosquitoes. Nat. Commun. 2014, 5, 4084.
12. Tsetsarkin, K.A.; Vanlandingham, D.L.; McGee, C.E.; Higgs, S. A Single Mutation in Chikungunya Virus Affects Vector Specificity and Epidemic Potential. PLoS Pathog. 2007, 3, e201.
13. Weaver, S.C. Arrival of Chikungunya Virus in the New World: Prospects for Spread and Impact on Public Health. PLoS Negl Trop. Dis. 2014, 8, e2921.
14. Powers, A.M.; Brault, A.C.; Shirako, Y.; Strauss, E.G.; Kang, W.; Strauss, J.H.; Weaver, S.C. Evolutionary Relationships and Systematics of the Alphaviruses. J. Virol. 2001, 75, 10118–10131.
15. Jose, J.; Snyder, J.E.; Kuhn, R.J. A Structural and Functional Perspective of Alphavirus Replication and Assembly. Future Microbiol. 2009, 4, 837–856.
16. Simizu, B.; Yamamoto, K.; Hashimoto, K.; Ogata, T. Structural Proteins of Chikungunya Virus. J. Virol. 1984, 51, 254–258.
17. Cao, S.; Zhang, W. Characterization of an Early-Stage Fusion Intermediate of Sindbis Virus using Cryoelectron Microscopy. Proc. Natl. Acad. Sci. USA 2013, 110, 13362–13367.
18. Allan, D.; Quinn, P. Membrane Phospholipid Asymmetry in Semliki Forest Virus Grown in BHK Cells. Biochim. Biophys. Acta Biomembr. 1989, 987, 199–204.
19. Renkonen, O.; Kaarainen, L.; Simons, K.; Gahmberg, C.G. The Lipid Class Composition of Semliki Forest Virus and Plasma Membranes of the Host Cells. Virology 1971, 46, 318–326.
20. Van Meer, G.; Simons, K.; Op den Kamp, J.A.; van Deenen, L.M. Phospholipid Asymmetry in Semliki Forest Virus Grown on Baby Hamster Kidney (BHK-21) Cells. Biochemistry 1981, 20, 1974–1981.
21. Kalvodova, L.; Sampaio, J.L.; Cordo, S.; Ejsing, C.S.; Shevchenko, A.; Simons, K. The Lipidomes of Vesicular Stomatitis Virus, Semliki Forest Virus, and the Host Plasma Membrane Analyzed by Quantitative Shotgun Mass Spectrometry. J. Virol. 2009, 83, 7996–8003.
22. Sun, S.; Xiang, Y.; Akahata, W.; Holdaway, H.; Pal, P.; Zhang, X.; Diamond, M.S.; Nabel, G.J.; Rossmann, M.G. Structural Analyses at Pseudo Atomic Resolution of Chikungunya Virus and Antibodies show Mechanisms of Neutralization. eLife 2013, 2, e00435.
23. Mukhopadhyay, S.; Zhang, W.; Gabler, S.; Chipman, P.R.; Strauss, E.G.; Strauss, J.H.; Baker, T.S.; Kuhn, R.J.; Rossmann, M.G. Mapping the Structure and Function of the E1 and E2 Glycoproteins in Alphaviruses. Structure 2006, 14, 63–73.
24. Lescar, J.; Roussel, A.; Wien, M.W.; Navaza, J.; Fuller, S.D.; Wengler, G.; Wengler, G.; Rey, F.A. The Fusion Glycoprotein Shell of Semliki Forest Virus: An Icosahedral Assembly Primed for Fusogenic Activation at Endosomal pH. Cell 2001, 105, 137–148.
25. Roussel, A.; Lescar, J.; Vaney, M.C.; Wengler, G.; Wengler, G.; Rey, F.A. Structure and Interactions at the Viral Surface of the Envelope Protein E1 of Semliki Forest Virus. Structure 2006, 14, 75–86.
26. Voss, J.E.; Vaney, M.C.; Duquerroy, S.; Vonrhein, C.; Girard-Blanc, C.; Crublet, E.; Thompson, A.; Bricogne, G.; Rey, F.A. Glycoprotein Organization of Chikungunya Virus Particles Revealed by X-ray Crystallography. Nature 2010, 468, 709–712.
27. Jose, J.; Przybyla, L.; Edwards, T.J.; Perera, R.; Burgner, J.W., 2nd; Kuhn, R.J. Interactions of the Cytoplasmic Domain of Sindbis Virus E2 with Nucleocapsid Cores Promote Alphavirus Budding. J. Virol. 2012, 86, 2585–2599.
28. Zhang, R.; Hryc, C.F.; Cong, Y.; Liu, X.; Jakana, J.; Gorchakov, R.; Baker, M.L.; Weaver, S.C.; Chiu, W. 4.4 A Cryo-EM Structure of an Enveloped Alphavirus Venezuelan Equine Encephalitis Virus. EMBO J. 2011, 30, 3854–3863.
29. Li, L.; Jose, J.; Xiang, Y.; Kuhn, R.J.; Rossmann, M.G. Structural Changes of Envelope Proteins during Alphavirus Fusion. Nature 2010, 468, 705–708.
30. Vogel, R.H.; Provencher, S.W.; von Bonsdorff, C.H.; Adrian, M.; Dubochet, J. Envelope Structure of Semliki Forest Virus Reconstructed from Cryo-Electron Micrographs. Nature 1986, 320, 533–535.
31. Pletnev, S.V.; Zhang, W.; Mukhopadhyay, S.; Fisher, B.R.; Hernandez, R.; Brown, D.T.; Baker, T.S.; Rossmann, M.G.; Kuhn, R.J. Locations of Carbohydrate Sites on Alphavirus Glycoproteins show that E1 Forms an Icosahedral Scaffold. Cell 2001, 105, 127–136.
32. Cheng, R.H.; Kuhn, R.J.; Olson, N.H.; Rossmann, M.G.; Choi, H.K.; Smith, T.J.; Baker, T.S. Nucleocapsid and Glycoprotein Organization in an Enveloped Virus. Cell 1995, 80, 621–630.
33. Reiter, P.; Fontenille, D.; Paupy, C. Aedes Albopictus as an Epidemic Vector of Chikungunya Virus: Another Emerging Problem? Lancet Infect. Dis. 2006, 6, 463–464.
34. Ramasubramanian, M.K.; Barham, O.M.; Swaminathan, V. Mechanics of a Mosquito Bite with Applications to Microneedle Design. Bioinspir. Biomim. 2008, 3.
35. Weaver, S.C.; Osorio, J.E.; Livengood, J.A.; Chen, R.; Stinchcomb, D.T. Chikungunya Virus and Prospects for a Vaccine. Expert Rev. Vaccines 2012, 11, 1087–1101.
36. Sourisseau, M.; Schilte, C.; Casartelli, N.; Trouillet, C.; Guivel-Benhassine, F.; Rudnicka, D.; Sol-Foulon, N.; Le Roux, K.; Prevost, M.C.; Fsihi, H.; et al. Characterization of Reemerging Chikungunya Virus. PLoS Pathog. 2007, 3, e89.
37. Solignat, M.; Gay, B.; Higgs, S.; Briant, L.; Devaux, C. Replication Cycle of Chikungunya: A Re-Emerging Arbovirus. Virology 2009, 393, 183–197.
38. Wikan, N.; Sakoonwatanyoo, P.; Ubol, S.; Yoksan, S.; Smith, D.R. Chikungunya Virus Infection of Cell Lines: Analysis of the East, Central and South African Lineage. PLoS ONE 2012, 7, e31102.
39. Chow, A.; Her, Z.; Ong, E.K.; Chen, J.M.; Dimatatac, F.; Kwek, D.J.; Barkham, T.; Yang, H.; Renia, L.; Leo, Y.S.; et al. Persistent Arthralgia Induced by Chikungunya Virus Infection is Associated with Interleukin-6 and Granulocyte Macrophage Colony-Stimulating Factor. J. Infect. Dis. 2011, 203, 149–157.
40. Naze, F.; Le Roux, K.; Schuffenecker, I.; Zeller, H.; Staikowsky, F.; Grivard, P.; Michault, A.; Laurent, P. Simultaneous Detection and Quantitation of Chikungunya, Dengue and West Nile Viruses by Multiplex RT-PCR Assays and Dengue Virus Typing using High Resolution Melting. J. Virol. Methods 2009, 162, 1–7.
41. Ng, L.C.; Tan, L.K.; Tan, C.H.; Tan, S.S.; Hapuarachchi, H.C.; Pok, K.Y.; Lai, Y.L.; Lam-Phua, S.G.; Bucht, G.; Lin, R.T.; et al. Entomologic and Virologic Investigation of Chikungunya, Singapore. Emerg. Infect. Dis. 2009, 15, 1243–1249.
42. Her, Z.; Malleret, B.; Chan, M.; Ong, E.K.; Wong, S.C.; Kwek, D.J.; Tolou, H.; Lin, R.T.; Tambyah, P.A.; Renia, L.; et al. Active Infection of Human Blood Monocytes by Chikungunya Virus Triggers an Innate Immune Response. J. Immunol. 2010, 184, 5903–5913.
43. Fraser, J.R.; Becker, G.J. Mononuclear Cell Types in Chronic Synovial Effusions of Ross River Virus Disease. Aust. N. Z. J. Med. 1984, 14, 505–506.
44. Gardner, C.L.; Burke, C.W.; Tesfay, M.Z.; Glass, P.J.; Klimstra, W.B.; Ryman, K.D. Eastern and Venezuelan Equine Encephalitis Viruses Differ in their Ability to Infect Dendritic Cells and Macrophages: Impact of Altered Cell Tropism on Pathogenesis. J. Virol. 2008, 82, 10634–10646.
45. Hidmark, A.S.; McInerney, G.M.; Nordstrom, E.K.; Douagi, I.; Werner, K.M.; Liljestrom, P.; Karlsson Hedestam, G.B. Early Alpha/Beta Interferon Production by Myeloid Dendritic Cells in Response to UV-Inactivated Virus Requires Viral Entry and Interferon Regulatory Factor 3 but Not MyD88. J. Virol. 2005, 79, 10376–10385.
46. Shabman, R.S.; Morrison, T.E.; Moore, C.; White, L.; Suthar, M.S.; Hueston, L.; Rulli, N.; Lidbury, B.; Ting, J.P.; Mahalingam, S.; et al. Differential Induction of Type I Interferon Responses in Myeloid Dendritic Cells by Mosquito and Mammalian-Cell-Derived Alphaviruses. J. Virol. 2007, 81, 237–247.
47. Schilte, C.; Couderc, T.; Chretien, F.; Sourisseau, M.; Gangneux, N.; Guivel-Benhassine, F.; Kraxner, A.; Tschopp, J.; Higgs, S.; Michault, A.; et al. Type I IFN Controls Chikungunya Virus Via its Action on Nonhematopoietic Cells. J. Exp. Med. 2010, 207, 429–442.
48. Vanlandingham, D.L.; Hong, C.; Klingler, K.; Tsetsarkin, K.; McElroy, K.L.; Powers, A.M.; Lehane, M.J.; Higgs, S. Differential Infectivities of O’Nyong-Nyong and Chikungunya Virus Isolates in Anopheles Gambiae and Aedes Aegypti Mosquitoes. Am. J. Trop. Med. Hyg. 2005, 72, 616–621.
49. Kumar, S.; Jaffar-Bandjee, M.C.; Giry, C.; Connen de Kerillis, L.; Merits, A.; Gasque, P.; Hoarau, J.J. Mouse Macrophage Innate Immune Response to Chikungunya Virus Infection. Virol. J. 2012, 9.
50. Issac, T.H.; Tan, E.L.; Chu, J.J. Proteomic Profiling of Chikungunya Virus-Infected Human Muscle Cells: Reveal the Role of Cytoskeleton Network in CHIKV Replication. J. Proteomics 2014, 108, 445–464.
51. Couderc, T.; Lecuit, M. Focus on Chikungunya Pathophysiology in Human and Animal Models. Microbes Infect. 2009, 11, 1197–1205.
52. Noret, M.; Herrero, L.; Rulli, N.; Rolph, M.; Smith, P.N.; Li, R.W.; Roques, P.; Gras, G.; Mahalingam, S. Interleukin 6, RANKL, and Osteoprotegerin Expression by Chikungunya Virus-Infected Human Osteoblasts. J. Infect. Dis. 2012, 206, 457–459.
53. Chen, W.; Foo, S.S.; Rulli, N.E.; Taylor, A.; Sheng, K.C.; Herrero, L.J.; Herring, B.L.; Lidbury, B.A.; Li, R.W.; Walsh, N.C.; et al. Arthritogenic Alphaviral Infection Perturbs Osteoblast Function and Triggers Pathologic Bone Loss. Proc. Natl. Acad. Sci. USA 2014, 111, 6040–6045.
54. Ozden, S.; Huerre, M.; Riviere, J.P.; Coffey, L.L.; Afonso, P.V.; Mouly, V.; de Monredon, J.; Roger, J.C.; El Amrani, M.; Yvin, J.L.; et al. Human Muscle Satellite Cells as Targets of Chikungunya Virus Infection. PLoS ONE 2007, 2, e527.
55. Couderc, T.; Chretien, F.; Schilte, C.; Disson, O.; Brigitte, M.; Guivel-Benhassine, F.; Touret, Y.; Barau, G.; Cayet, N.; Schuffenecker, I.; et al. A Mouse Model for Chikungunya: Young Age and Inefficient Type-I Interferon Signaling are Risk Factors for Severe Disease. PLoS Pathog. 2008, 4, e29.
56. Brighton, S.W.; Simson, I.W. A Destructive Arthropathy Following Chikungunya Virus Arthritis—A Possible Association. Clin. Rheumatol. 1984, 3, 253–258.
57. Marimoutou, C.; Ferraro, J.; Javelle, E.; Deparis, X.; Simon, F. Chikungunya Infection: Self-Reported Rheumatic Morbidity and Impaired Quality of Life Persist 6 Years Later. Clin. Microbiol. Infect. 2015, 21, 688–693.
58. Mathew, A.J.; Goyal, V.; George, E.; Thekkemuriyil, D.V.; Jayakumar, B.; Chopra, A.; Trivandrum COPCORD Study Group. Rheumatic-Musculoskeletal Pain and Disorders in a Naive Group of Individuals 15 Months Following a Chikungunya Viral Epidemic in South India: A Population Based Observational Study. Int. J. Clin. Pract. 2011, 65, 1306–1312.
59. Foissac, M.; Javelle, E.; Ray, S.; Guerin, B.; Simon, F. Post-Chikungunya Rheumatoid Arthritis, Saint Martin. Emerg. Infect. Dis. 2015, 21, 530–532.
60. Queyriaux, B.; Simon, F.; Grandadam, M.; Michel, R.; Tolou, H.; Boutin, J.P. Clinical Burden of Chikungunya Virus Infection. Lancet Infect. Dis. 2008, 8, 2–3.
61. Tang, B.L. The Cell Biology of Chikungunya Virus Infection. Cell. Microbiol. 2012, 14, 1354–1363.
62. 62. Chen, W.; Foo, S.S.; Sims, N.A.; Herrero, L.J.; Walsh, N.C.; Mahalingam, S. Arthritogenic Alphaviruses: New Insights into Arthritis and Bone Pathology. Trends Microbiol. 2015, 23, 35–43.
63. Labadie, K.; Larcher, T.; Joubert, C.; Mannioui, A.; Delache, B.; Brochard, P.; Guigand, L.; Dubreil, L.; Lebon, P.; Verrier, B.; et al. Chikungunya Disease in Nonhuman Primates Involves Long-Term Viral Persistence in Macrophages. J. Clin. Investig. 2010, 120, 894–906.
64. Malvy, D.; Ezzedine, K.; Mamani-Matsuda, M.; Autran, B.; Tolou, H.; Receveur, M.C.; Pistone, T.; Rambert, J.; Moynet, D.; Mossalayi, D. Destructive Arthritis in a Patient with Chikungunya Virus Infection with Persistent Specific IgM Antibodies. BMC Infect. Dis. 2009, 9.
65. Wielanek, A.C.; Monredon, J.D.; Amrani, M.E.; Roger, J.C.; Serveaux, J.P. Guillain-Barre Syndrome Complicating a Chikungunya Virus Infection. Neurology 2007, 69, 2105–2107.
66. Lebrun, G.; Chadda, K.; Reboux, A.H.; Martinet, O.; Gauzere, B.A. Guillain-Barre Syndrome After Chikungunya Infection. Emerg. Infect. Dis. 2009, 15, 495–496.
67. Chusri, S.; Siripaitoon, P.; Hirunpat, S.; Silpapojakul, K. Case Reports of Neuro-Chikungunya in Southern Thailand. Am. J. Trop. Med. Hyg. 2011, 85, 386–389.
68. Grivard, P.; Le Roux, K.; Laurent, P.; Fianu, A.; Perrau, J.; Gigan, J.; Hoarau, G.; Grondin, N.; Staikowsky, F.; Favier, F.; et al. Molecular and Serological Diagnosis of Chikungunya Virus Infection. Pathol. Biol. (Paris) 2007, 55, 490–494.
69. Wintachai, P.; Wikan, N.; Kuadkitkan, A.; Jaimipuk, T.; Ubol, S.; Pulmanausahakul, R.; Auewarakul, P.; Kasinrerk, W.; Weng, W.Y.; Panyasrivanit, M.; et al. Identification of Prohibitin as a Chikungunya Virus Receptor Protein. J. Med. Virol. 2012, 84, 1757–1770.
70. Abraham, R.; Mudaliar, P.; Padmanabhan, A.; Sreekumar, E. Induction of Cytopathogenicity in Human Glioblastoma Cells by Chikungunya Virus. PLoS ONE 2013, 8, e75854.
71. Lim, P.J.; Chu, J.J. A Polarized Cell Model for Chikungunya Virus Infection: Entry and Egress of Virus Occurs at the Apical Domain of Polarized Cells. PLoS Negl. Trop. Dis. 2014, 8, e2661.
72. Haywood, A.M. Virus Receptors: Binding, Adhesion Strengthening, and Changes in Viral Structure. J. Virol. 1994, 68, 1–5.
73. Mercer, J.; Schelhaas, M.; Helenius, A. Virus Entry by Endocytosis. Annu. Rev. Biochem. 2010, 79, 803–833.
74. Smith, T.J.; Cheng, R.H.; Olson, N.H.; Peterson, P.; Chase, E.; Kuhn, R.J.; Baker, T.S. Putative Receptor Binding Sites on Alphaviruses as Visualized by Cryoelectron Microscopy. Proc. Natl. Acad. Sci. USA 1995, 92, 10648–10652.
75. Ashbrook, A.W.; Burrack, K.S.; Silva, L.A.; Montgomery, S.A.; Heise, M.T.; Morrison, T.E.; Dermody, T.S. Residue 82 of the Chikungunya Virus E2 Attachment Protein Modulates Viral Dissemination and Arthritis in Mice. J. Virol. 2014, 88, 12180–12192.
76. 76. Asnet Mary, J.; Paramasivan, R.; Tyagi, B.K.; Surender, M.; Shenbagarathai, R. Identification of Structural Motifs in the E2 Glycoprotein of Chikungunya Involved in Virus-Host Interaction. J. Biomol. Struct. Dyn. 2013, 31, 1077–1085.
77. Ye, F.; Zhang, M. Structures and Target Recognition Modes of PDZ Domains: Recurring Themes and Emerging Pictures. Biochem. J. 2013, 455, 1–14.
78. Yan, Y.; Vasudevan, S.; Nguyen, H.; Bork, U.; Sitaraman, S.; Merlin, D. Extracellular Interaction between hCD98 and the PDZ Class II Domain of hCASK in Intestinal Epithelia. J. Membr. Biol. 2007, 215, 15–26.
79. Moller-Tank, S.; Kondratowicz, A.S.; Davey, R.A.; Rennert, P.D.; Maury, W. Role of the Phosphatidylserine Receptor TIM-1 in Enveloped-Virus Entry. J. Virol. 2013, 87, 8327–8341.
80. Silva, L.A.; Khomandiak, S.; Ashbrook, A.W.; Weller, R.; Heise, M.T.; Morrison, T.E.; Dermody, T.S. A Single-Amino-Acid Polymorphism in Chikungunya Virus E2 Glycoprotein Influences Glycosaminoglycan Utilization. J. Virol. 2014, 88, 2385–2397.
81. Fongsaran, C.; Jirakanwisal, K.; Kuadkitkan, A.; Wikan, N.; Wintachai, P.; Thepparit, C.; Ubol, S.; Phaonakrop, N.; Roytrakul, S.; Smith, D.R. Involvement of ATP Synthase Beta Subunit in Chikungunya Virus Entry into Insect Cells. Arch. Virol. 2014, 159, 3353–3364.
82. Marsh, M.; Helenius, A. Virus Entry: Open Sesame. Cell 2006, 124, 729–740.
83. Salvador, B.; Zhou, Y.; Michault, A.; Muench, M.O.; Simmons, G. Characterization of Chikungunya Pseudotyped Viruses: Identification of Refractory Cell Lines and Demonstration of Cellular Tropism Differences Mediated by Mutations in E1 Glycoprotein. Virology 2009, 393, 33–41.
84. Chowdhury, I.; Thompson, W.E.; Thomas, K. Prohibitins Role in Cellular Survival through Ras-Raf-MEK-ERK Pathway. J. Cell. Physiol. 2014, 229, 998–1004.
85. Hossen, M.N.; Kajimoto, K.; Akita, H.; Hyodo, M.; Harashima, H. Vascular-Targeted Nanotherapy for Obesity: Unexpected Passive Targeting Mechanism to Obese Fat for the Enhancement of Active Drug Delivery. J. Control. Release 2012, 163, 101–110.
86. Kolonin, M.G.; Saha, P.K.; Chan, L.; Pasqualini, R.; Arap, W. Reversal of Obesity by Targeted Ablation of Adipose Tissue. Nat. Med. 2004, 10, 625–632.
87. Merkwirth, C.; Langer, T. Prohibitin Function within Mitochondria: Essential Roles for Cell Proliferation and Cristae Morphogenesis. Biochim. Biophys. Acta 2009, 1793, 27–32.
88. Wintachai, P.; Thuaud, F.; Basmadjian, C.; Roytrakul, S.; Ubol, S.; Desaubry, L.; Smith, D.R. Assessment of Flavaglines as Potential Chikungunya Virus Entry Inhibitors. Microbiol. Immunol. 2015, 59, 129–141.
89. Umetsu, S.E.; Lee, W.L.; McIntire, J.J.; Downey, L.; Sanjanwala, B.; Akbari, O.; Berry, G.J.; Nagumo, H.; Freeman, G.J.; Umetsu, D.T.; et al. TIM-1 Induces T Cell Activation and Inhibits the Development of Peripheral Tolerance. Nat. Immunol. 2005, 6, 447–454.
90. 90. Zhu, C.; Anderson, A.C.; Schubart, A.; Xiong, H.; Imitola, J.; Khoury, S.J.; Zheng, X.X.; Strom, T.B.; Kuchroo, V.K. The Tim-3 Ligand Galectin-9 Negatively Regulates T Helper Type 1 Immunity. Nat. Immunol. 2005, 6, 1245–1252.
91. Kobayashi, N.; Karisola, P.; Pena-Cruz, V.; Dorfman, D.M.; Jinushi, M.; Umetsu, S.E.; Butte, M.J.; Nagumo, H.; Chernova, I.; Zhu, B.; et al. TIM-1 and TIM-4 Glycoproteins Bind Phosphatidylserine and Mediate Uptake of Apoptotic Cells. Immunity 2007, 27, 927–940.
92. Kondratowicz, A.S.; Lennemann, N.J.; Sinn, P.L.; Davey, R.A.; Hunt, C.L.; Moller-Tank, S.; Meyerholz, D.K.; Rennert, P.; Mullins, R.F.; Brindley, M.; et al. T-Cell Immunoglobulin and Mucin Domain 1 (TIM-1) is a Receptor for Zaire Ebolavirus and Lake Victoria Marburgvirus. Proc. Natl. Acad. Sci. USA 2011, 108, 8426–8431.
93. Moller-Tank, S.; Albritton, L.M.; Rennert, P.D.; Maury, W. Characterizing Functional Domains for TIM-Mediated Enveloped Virus Entry. J. Virol. 2014, 88, 6702–6713.
94. Gandhi, N.S.; Mancera, R.L. The Structure of Glycosaminoglycans and their Interactions with Proteins. Chem. Biol. Drug Des. 2008, 72, 455–482.
95. Klimstra, W.B.; Ryman, K.D.; Johnston, R.E. Adaptation of Sindbis Virus to BHK Cells Selects for use of Heparan Sulfate as an Attachment Receptor. J. Virol. 1998, 72, 7357–7366.
96. Bernard, K.A.; Klimstra, W.B.; Johnston, R.E. Mutations in the E2 Glycoprotein of Venezuelan Equine Encephalitis Virus Confer Heparan Sulfate Interaction, Low Morbidity, and Rapid Clearance from Blood of Mice. Virology 2000, 276, 93–103.
97. Gardner, C.L.; Choi-Nurvitadhi, J.; Sun, C.; Bayer, A.; Hritz, J.; Ryman, K.D.; Klimstra, W.B. Natural Variation in the Heparan Sulfate Binding Domain of the Eastern Equine Encephalitis Virus E2 Glycoprotein Alters Interactions with Cell Surfaces and Virulence in Mice. J. Virol. 2013, 87, 8582–8590.
98. Smit, J.M.; Waarts, B.L.; Kimata, K.; Klimstra, W.B.; Bittman, R.; Wilschut, J. Adaptation of Alphaviruses to Heparan Sulfate: Interaction of Sindbis and Semliki Forest Viruses with Liposomes Containing Lipid-Conjugated Heparin. J. Virol. 2002, 76, 10128–10137.
99. Bear, J.S.; Byrnes, A.P.; Griffin, D.E. Heparin-Binding and Patterns of Virulence for Two Recombinant Strains of Sindbis Virus. Virology 2006, 347, 183–190.
100. Wang, E.; Brault, A.C.; Powers, A.M.; Kang, W.; Weaver, S.C. Glycosaminoglycan Binding Properties of Natural Venezuelan Equine Encephalitis Virus Isolates. J. Virol. 2003, 77, 1204–1210.
101. Heil, M.L.; Albee, A.; Strauss, J.H.; Kuhn, R.J. An Amino Acid Substitution in the Coding Region of the E2 Glycoprotein Adapts Ross River Virus to Utilize Heparan Sulfate as an Attachment Moiety. J. Virol. 2001, 75, 6303–6309.
102. Gardner, C.L.; Burke, C.W.; Higgs, S.T.; Klimstra, W.B.; Ryman, K.D. Interferon-Alpha/Beta Deficiency Greatly Exacerbates Arthritogenic Disease in Mice Infected with Wild-Type Chikungunya Virus but Not with the Cell Culture-Adapted Live-Attenuated 181/25 Vaccine Candidate. Virology 2012, 425, 103–112.
103. Levitt, N.H.; Ramsburg, H.H.; Hasty, S.E.; Repik, P.M.; Cole, F.E., Jr.; Lupton, H.W. Development of an Attenuated Strain of Chikungunya Virus for use in Vaccine Production. Vaccine 1986, 4, 157–162.
104. Gardner, C.L.; Hritz, J.; Sun, C.; Vanlandingham, D.L.; Song, T.Y.; Ghedin, E.; Higgs, S.; Klimstra, W.B.; Ryman, K.D. Deliberate Attenuation of Chikungunya Virus by Adaptation to Heparan Sulfate-Dependent Infectivity: A Model for Rational Arboviral Vaccine Design. PLoS Negl. Trop. Dis. 2014, 8, e2719.
105. Gorchakov, R.; Wang, E.; Leal, G.; Forrester, N.L.; Plante, K.; Rossi, S.L.; Partidos, C.D.; Adams, A.P.; Seymour, R.L.; Weger, J.; et al. Attenuation of Chikungunya Virus Vaccine Strain 181/Clone 25 is Determined by Two Amino Acid Substitutions in the E2 Envelope Glycoprotein. J. Virol. 2012, 86, 6084–6096.
106. National Center for Biotechnology Information. ATP5B ATP Synthase, H+ Transporting, Mitochondrial F1 Complex, Beta Polypeptide [Homo Sapiens (Human)]; National Center for Biotechnology Information: Bethesda, MD, USA, 2015; Available online: http://www. ncbi.nlm.nih.gov/gene/506 or http://www.webcitation.org/6YE9a0jmy (accessed on 2 May 2015).
107. Fu, Y.; Hou, Y.; Fu, C.; Gu, M.; Li, C.; Kong, W.; Wang, X.; Shyy, J.Y.; Zhu, Y. A Novel Mechanism of Gamma/Delta T-Lymphocyte and Endothelial Activation by Shear Stress: The Role of Ecto-ATP Synthase Beta Chain. Circ. Res. 2011, 108, 410–417.
108. Champagne, E.; Martinez, L.O.; Collet, X.; Barbaras, R. Ecto-F1Fo ATP Synthase/F1 ATPase: Metabolic and Immunological Functions. Curr. Opin. Lipidol. 2006, 17, 279–284.
109. Takada, Y.; Ye, X.; Simon, S. The Integrins. Genome Biol. 2007, 8, e215.
110. Fraisier, C.; Koraka, P.; Belghazi, M.; Bakli, M.; Granjeaud, S.; Pophillat, M.; Lim, S.M.; Osterhaus, A.; Martina, B.; Camoin, L.; et al. Kinetic Analysis of Mouse Brain Proteome Alterations Following Chikungunya Virus Infection before and After Appearance of Clinical Symptoms. PLoS ONE 2014, 9, e91397.
111. Mathias, P.; Wickham, T.; Moore, M.; Nemerow, G. Multiple Adenovirus Serotypes use Alpha V Integrins for Infection. J. Virol. 1994, 68, 6811–6814.
112. Li, E.; Brown, S.L.; Stupack, D.G.; Puente, X.S.; Cheresh, D.A.; Nemerow, G.R. Integrin Alpha(V)Beta1 is an Adenovirus Coreceptor. J. Virol. 2001, 75, 5405–5409.
113. La Linn, M.; Eble, J.A.; Lubken, C.; Slade, R.W.; Heino, J.; Davies, J.; Suhrbier, A. An Arthritogenic Alphavirus Uses the alpha1beta1 Integrin Collagen Receptor. Virology 2005, 336, 229–239.
114. Schmidt, K.; Keller, M.; Bader, B.L.; Korytar, T.; Finke, S.; Ziegler, U.; Groschup, M.H. Integrins Modulate the Infection Efficiency of West Nile Virus into Cells. J. Gen. Virol. 2013, 94, 1723–1733.
115. Nakamura, H.; Minegishi, H. HSP60 as a Drug Target. Curr. Pharm. Des. 2013, 19, 441–451.
116. Soltys, B.J.; Gupta, R.S. Cell Surface Localization of the 60 kDa Heat Shock Chaperonin Protein (hsp60) in Mammalian Cells. Cell Biol. Int. 1997, 21, 315–320.
117. Belles, C.; Kuhl, A.; Nosheny, R.; Carding, S.R. Plasma Membrane Expression of Heat Shock Protein 60 in vivo in Response to Infection. Infect. Immun. 1999, 67, 4191–4200.
118. Apte-Deshpande, A.D.; Paingankar, M.S.; Gokhale, M.D.; Deobagkar, D.N. Serratia Odorifera Mediated Enhancement in Susceptibility of Aedes Aegypti for Chikungunya Virus. Indian J. Med. Res. 2014, 139, 762–768.
119. Padwad, Y.S.; Mishra, K.P.; Jain, M.; Chanda, S.; Karan, D.; Ganju, L. RNA Interference Mediated Silencing of Hsp60 Gene in Human Monocytic Myeloma Cell Line U937 Revealed Decreased Dengue Virus Multiplication. Immunobiology 2009, 214, 422–429.
120. Vancini, R.; Wang, G.; Ferreira, D.; Hernandez, R.; Brown, D.T. Alphavirus Genome Delivery Occurs Directly at the Plasma Membrane in a Time- and Temperature-Dependent Process. J. Virol. 2013, 87, 4352–4359.
121. Paredes, A.M.; Ferreira, D.; Horton, M.; Saad, A.; Tsuruta, H.; Johnston, R.; Klimstra, W.; Ryman, K.; Hernandez, R.; Chiu, W.; et al. Conformational Changes in Sindbis Virions Resulting from Exposure to Low pH and Interactions with Cells Suggest that Cell Penetration may Occur at the Cell Surface in the Absence of Membrane Fusion. Virology 2004, 324, 373–386.
122. Benmerah, A.; Lamaze, C. Clathrin-Coated Pits: Vive La Difference? Traffic 2007, 8, 970–982.
123. Kirchhausen, T.; Owen, D.; Harrison, S.C. Molecular Structure, Function, and Dynamics of Clathrin-Mediated Membrane Traffic. Cold Spring Harb. Perspect. Biol. 2014, 6.
124. Colpitts, T.M.; Moore, A.C.; Kolokoltsov, A.A.; Davey, R.A. Venezuelan Equine Encephalitis Virus Infection of Mosquito Cells Requires Acidification as Well as Mosquito Homologs of the Endocytic Proteins Rab5 and Rab7. Virology 2007, 369, 78–91.
125. Marsh, M.; Bolzau, E.; Helenius, A. Penetration of Semliki Forest Virus from Acidic Prelysosomal Vacuoles. Cell 1983, 32, 931–940.
126. Kolokoltsov, A.A.; Fleming, E.H.; Davey, R.A. Venezuelan Equine Encephalitis Virus Entry Mechanism Requires Late Endosome Formation and Resists Cell Membrane Cholesterol Depletion. Virology 2006, 347, 333–342.
127. Yamauchi, Y.; Helenius, A. Virus Entry at a Glance. J. Cell. Sci. 2013, 126, 1289–1295.
128. Gold, E.S.; Underhill, D.M.; Morrissette, N.S.; Guo, J.; McNiven, M.A.; Aderem, A. Dynamin 2 is Required for Phagocytosis in Macrophages. J. Exp. Med. 1999, 190, 1849–1856.
129. Bernard, E.; Solignat, M.; Gay, B.; Chazal, N.; Higgs, S.; Devaux, C.; Briant, L. Endocytosis of Chikungunya Virus into Mammalian Cells: Role of Clathrin and Early Endosomal Compartments. PLoS ONE 2010, 5, e11479.
130. Sigismund, S.; Woelk, T.; Puri, C.; Maspero, E.; Tacchetti, C.; Transidico, P.; Di Fiore, P.P.; Polo, S. Clathrin-Independent Endocytosis of Ubiquitinated Cargos. Proc. Natl. Acad. Sci. USA 2005, 102, 2760–2765.
131. Ooi, Y.S.; Stiles, K.M.; Liu, C.Y.; Taylor, G.M.; Kielian, M. Genome-Wide RNAi Screen Identifies Novel Host Proteins Required for Alphavirus Entry. PLoS Pathog. 2013, 9, e1003835.
132. Hoornweg, T.E.; van Duijl-Richter, M.K.S.; Ayala Nuñez, N.V.; van Hemert, M.J.; Smit, J.M. Dynamics of Chikungunya Virus Cell Entry Unraveled by Single Virus Tracking in Living Cells. Submitted.
133. Lee, R.C.; Hapuarachchi, H.C.; Chen, K.C.; Hussain, K.M.; Chen, H.; Low, S.L.; Ng, L.C.; Lin, R.; Ng, M.M.; Chu, J.J. Mosquito Cellular Factors and Functions in Mediating the Infectious Entry of Chikungunya Virus. PLoS Negl. Trop. Dis. 2013, 7, e2050.
134. The Murphy Lab. Differences in Early Endosomal pH between Cell Types, Available online: http://murphylab.web.cmu.edu/projects/endosomal-pH-references.html or http://www. webcita-tion.org/6YFhQFTB1. (accessed on 3 May 2015).
135. Van Duijl-Richter, M.; Blijleven, J.; van Oijen, A.; Smit, J. Chikungunya Virus Fusion Properties Elucidated by Single-Particle and Bulk Approaches. J. Gen. Virol. 2015.
136. Zeng, X.; Mukhopadhyay, S.; Brooks, C.L., 3rd. Residue-Level Resolution of Alphavirus Envelope Protein Interactions in pH-Dependent Fusion. Proc. Natl. Acad. Sci. USA 2015, 112, 2034–2039.
137. White, J.; Helenius, A. pH-Dependent Fusion between the Semliki Forest Virus Membrane and Liposomes. Proc. Natl. Acad. Sci. USA 1980, 77, 3273–3277.
138. Bron, R.; Wahlberg, J.M.; Garoff, H.; Wilschut, J. Membrane Fusion of Semliki Forest Virus in a Model System: Correlation between Fusion Kinetics and Structural Changes in the Envelope Glycoprotein. EMBO J. 1993, 12, 693–701.
139. Smit, J.M.; Bittman, R.; Wilschut, J. Low-pH-Dependent Fusion of Sindbis Virus with Receptor-Free Cholesterol- and Sphingolipid-Containing Liposomes. J. Virol. 1999, 73, 8476–8484.
140. Wahlberg, J.M.; Boere, W.A.; Garoff, H. The Heterodimeric Association between the Membrane Proteins of Semliki Forest Virus Changes its Sensitivity to Low pH during Virus Maturation. J. Virol. 1989, 63, 4991–4997.
141. Kampmann, T.; Mueller, D.S.; Mark, A.E.; Young, P.R.; Kobe, B. The Role of Histidine Residues in Low-pH-Mediated Viral Membrane Fusion. Structure 2006, 14, 1481–1487.
142. Fields, W.; Kielian, M. A Key Interaction between the Alphavirus Envelope Proteins Responsible for Initial Dimer Dissociation during Fusion. J. Virol. 2013, 87, 3774–3781.
143. Hammar, L.; Markarian, S.; Haag, L.; Lankinen, H.; Salmi, A.; Cheng, R.H. Prefusion Rearrangements Resulting in Fusion Peptide Exposure in Semliki Forest Virus. J. Biol. Chem. 2003, 278, 7189–7198.
144. Gibbons, D.L.; Ahn, A.; Liao, M.; Hammar, L.; Cheng, R.H.; Kielian, M. Multistep Regulation of Membrane Insertion of the Fusion Peptide of Semliki Forest Virus. J. Virol. 2004, 78, 3312–3318.
145. Kielian, M.; Rey, F.A. Virus Membrane-Fusion Proteins: More than One Way to make a Hairpin. Nat. Rev. Microbiol. 2006, 4, 67–76.
146. Ahn, A.; Gibbons, D.L.; Kielian, M. The Fusion Peptide of Semliki Forest Virus Associates with Sterol-Rich Membrane Domains. J. Virol. 2002, 76, 3267–3275.
147. Klimjack, M.R.; Jeffrey, S.; Kielian, M. Membrane and Protein Interactions of a Soluble Form of the Semliki Forest Virus Fusion Protein. J. Virol. 1994, 68, 6940–6946.
148. Nieva, J.L.; Bron, R.; Corver, J.; Wilschut, J. Membrane Fusion of Semliki Forest Virus Requires Sphingolipids in the Target Membrane. EMBO J. 1994, 13, 2797–2804.
149. Vashishtha, M.; Phalen, T.; Marquardt, M.T.; Ryu, J.S.; Ng, A.C.; Kielian, M. A Single Point Mutation Controls the Cholesterol Dependence of Semliki Forest Virus Entry and Exit. J. Cell Biol. 1998, 140, 91–99.
150. Chatterjee, P.K.; Vashishtha, M.; Kielian, M. Biochemical Consequences of a Mutation that Controls the Cholesterol Dependence of Semliki Forest Virus Fusion. J. Virol. 2000, 74, 1623–1631.
151. Lu, Y.E.; Cassese, T.; Kielian, M. The Cholesterol Requirement for Sindbis Virus Entry and Exit and Characterization of a Spike Protein Region Involved in Cholesterol Dependence. J. Virol. 1999, 73, 4272–4278.
152. Gay, B.; Bernard, E.; Solignat, M.; Chazal, N.; Devaux, C.; Briant, L. pH-Dependent Entry of Chikungunya Virus into Aedes Albopictus Cells. Infect. Genet. Evol. 2012, 12, 1275–1281.
153. Tsetsarkin, K.A.; Weaver, S.C. Sequential Adaptive Mutations Enhance Efficient Vector Switching by Chikungunya Virus and its Epidemic Emergence. PLoS Pathog. 2011, 7, e1002412.
154. Kuo, S.C.; Chen, Y.J.; Wang, Y.M.; Tsui, P.Y.; Kuo, M.D.; Wu, T.Y.; Lo, S.J. Cell-Based Analysis of Chikungunya Virus E1 Protein in Membrane Fusion. J. Biomed. Sci. 2012, 19, e44.
155. Chatterjee, P.K.; Eng, C.H.; Kielian, M. Novel Mutations that Control the Sphingolipid and Cholesterol Dependence of the Semliki Forest Virus Fusion Protein. J. Virol. 2002, 76, 12712–12722.
156. Teissier, E.; Pecheur, E.I. Lipids as Modulators of Membrane Fusion Mediated by Viral Fusion Proteins. Eur. Biophys. J. 2007, 36, 887–899.
157. Wahlberg, J.M.; Bron, R.; Wilschut, J.; Garoff, H. Membrane Fusion of Semliki Forest Virus Involves Homotrimers of the Fusion Protein. J. Virol. 1992, 66, 7309–7318.
158. Zheng, Y.; Sanchez-San Martin, C.; Qin, Z.L.; Kielian, M. The Domain I-Domain III Linker Plays an Important Role in the Fusogenic Conformational Change of the Alphavirus Membrane Fusion Protein. J. Virol. 2011, 85, 6334–6342.
159. Qin, Z.L.; Zheng, Y.; Kielian, M. Role of Conserved Histidine Residues in the Low-pH Dependence of the Semliki Forest Virus Fusion Protein. J. Virol. 2009, 83, 4670–4677.
160. Gibbons, D.L.; Vaney, M.C.; Roussel, A.; Vigouroux, A.; Reilly, B.; Lepault, J.; Kielian, M.; Rey, F.A. Conformational Change and Protein-Protein Interactions of the Fusion Protein of Semliki Forest Virus. Nature 2004, 427, 320–325.
161. Sanchez-San Martin, C.; Sosa, H.; Kielian, M. A Stable Prefusion Intermediate of the Alphavirus Fusion Protein Reveals Critical Features of Class II Membrane Fusion. Cell Host Microbe 2008, 4, 600–608.
162. Sanchez-San Martin, C.; Nanda, S.; Zheng, Y.; Fields, W.; Kielian, M. Cross-Inhibition of Chikungunya Virus Fusion and Infection by Alphavirus E1 Domain III Proteins. J. Virol. 2013, 87, 7680–7687.
163. Wengler, G.; Koschinski, A.; Wengler, G.; Repp, H. During Entry of Alphaviruses, the E1 Glycoprotein Molecules Probably Form Two Separate Populations that Generate either a Fusion Pore Or Ion-Permeable Pores. J. Gen. Virol. 2004, 85, 1695–1701.
164. Kaur, P.; Chu, J.J. Chikungunya Virus: An Update on Antiviral Development and Challenges. Drug Discov. Today 2013, 18, 969–983.
165. Weber, C.; Sliva, K.; von Rhein, C.; Kummerer, B.M.; Schnierle, B.S. The Green Tea Catechin, Epigallocatechin Gallate Inhibits Chikungunya Virus Infection. Antiviral Res. 2015, 113, 1–3.
166. Colpitts, C.C.; Schang, L.M. A Small Molecule Inhibits Virion Attachment to Heparan Sulfate- or Sialic Acid-Containing Glycans. J. Virol. 2014, 88, 7806–7817.
167. Couderc, T.; Khandoudi, N.; Grandadam, M.; Visse, C.; Gangneux, N.; Bagot, S.; Prost, J.F.; Lecuit, M. Prophylaxis and Therapy for Chikungunya Virus Infection. J. Infect. Dis. 2009, 200, 516–523.
168. Fric, J.; Bertin-Maghit, S.; Wang, C.I.; Nardin, A.; Warter, L. Use of Human Monoclonal Antibodies to Treat Chikungunya Virus Infection. J. Infect. Dis. 2013, 207, 319–322.
169. Fong, R.H.; Banik, S.S.; Mattia, K.; Barnes, T.; Tucker, D.; Liss, N.; Lu, K.; Selvarajah, S.; Srinivasan, S.; Mabila, M.; et al. Exposure of Epitope Residues on the Outer Face of the Chikungunya Virus Envelope Trimer Determines Antibody Neutralizing Efficacy. J. Virol. 2014, 88, 14364–14379.
170. Pohjala, L.; Utt, A.; Varjak, M.; Lulla, A.; Merits, A.; Ahola, T.; Tammela, P. Inhibitors of Alphavirus Entry and Replication Identified with a Stable Chikungunya Replicon Cell Line and Virus-Based Assays. PLoS ONE 2011, 6, e28923.
171. Gastaminza, P.; Whitten-Bauer, C.; Chisari, F.V. Unbiased Probing of the Entire Hepatitis C Virus Life Cycle Identifies Clinical Compounds that Target Multiple Aspects of the Infection. Proc. Natl. Acad. Sci. USA 2010, 107, 291–296.
172. De Lamballerie, X.; Boisson, V.; Reynier, J.C.; Enault, S.; Charrel, R.N.; Flahault, A.; Roques, P.; Le Grand, R. On Chikungunya Acute Infection and Chloroquine Treatment. Vector Borne Zoonotic Dis. 2008, 8, 837–839.
173. Khan, M.; Santhosh, S.R.; Tiwari, M.; Lakshmana Rao, P.V.; Parida, M. Assessment of in vitro Prophylactic and Therapeutic Efficacy of Chloroquine Against Chikungunya Virus in Vero Cells. J. Med. Virol. 2010, 82, 817–824.
174. Delogu, I.; de Lamballerie, X. Chikungunya Disease and Chloroquine Treatment. J. Med. Virol. 2011, 83, 1058–1059.
175. Nuckols, J.T.; McAuley, A.J.; Huang, Y.J.; Horne, K.M.; Higgs, S.; Davey, R.A.; Vanlandingham, D.L. pH-Dependent Entry of Chikungunya Virus Fusion into Mosquito Cells. Virol. J. 2014, 11.
176. Liao, M.; Kielian, M. Domain III from Class II Fusion Proteins Functions as a Dominant-Negative Inhibitor of Virus Membrane Fusion. J. Cell Biol. 2005, 171, 111–120.
177. Delogu, I.; Pastorino, B.; Baronti, C.; Nougairede, A.; Bonnet, E.; de Lamballerie, X. In vitro Antiviral Activity of Arbidol Against Chikungunya Virus and Characteristics of a Selected Resistant Mutant. Antiviral Res. 2011, 90, 99–107.
178. Di Mola, A.; Peduto, A.; La Gatta, A.; Delang, L.; Pastorino, B.; Neyts, J.; Leyssen, P.; de Rosa, M.; Filosa, R. Structure-Activity Relationship Study of Arbidol Derivatives as Inhibitors of Chikungunya Virus Replication. Bioorg. Med. Chem. 2014, 22, 6014–6025.
179. Villalain, J. Membranotropic Effects of Arbidol, a Broad Anti-Viral Molecule, on Phospholipid Model Membranes. J. Phys. Chem. B 2010, 114, 8544–8554.
180. Boriskin, Y.S.; Leneva, I.A.; Pecheur, E.I.; Polyak, S.J. Arbidol: A Broad-Spectrum Antiviral Compound that Blocks Viral Fusion. Curr. Med. Chem. 2008, 15, 997–1005.
181. Selvarajah, S.; Sexton, N.R.; Kahle, K.M.; Fong, R.H.; Mattia, K.A.; Gardner, J.; Lu, K.; Liss, N.M.; Salvador, B.; Tucker, D.F.; et al. A Neutralizing Monoclonal Antibody Targeting the Acid-Sensitive Region in Chikungunya Virus E2 Protects from Disease. PLoS Negl. Trop. Dis. 2013, 7, e2423.
182. Pal, P.; Dowd, K.A.; Brien, J.D.; Edeling, M.A.; Gorlatov, S.; Johnson, S.; Lee, I.; Akahata, W.; Nabel, G.J.; Richter, M.K.; et al. Development of a Highly Protective Combination Monoclonal Antibody Therapy Against Chikungunya Virus. PLoS Pathog. 2013, 9, e1003312.
183. Long, K.M.; Whitmore, A.C.; Ferris, M.T.; Sempowski, G.D.; McGee, C.; Trollinger, B.; Gunn, B.; Heise, M.T. Dendritic Cell Immunoreceptor Regulates Chikungunya Virus Pathogenesis in Mice. J. Virol. 2013, 87, 5697–5706.
184. Linn, M.L.; Aaskov, J.G.; Suhrbier, A. Antibody-Dependent Enhancement and Persistence in Macrophages of an Arbovirus Associated with Arthritis. J. Gen. Virol. 1996, 77, 407–411.
185. Ryman, K.D.; Klimstra, W.B. Closing the Gap between Viral and Noninfectious Arthritis. Proc. Natl. Acad. Sci. USA 2014, 111, 5767–5768.
186. Zhang, X.; Sheng, J.; Austin, S.K.; Hoornweg, T.E.; Smit, J.M.; Kuhn, R.J.; Diamond, M.S.; Rossmann, M.G. Structure of Acidic pH Dengue Virus Showing the Fusogenic Glycoprotein Trimers. J. Virol. 2015, 89, 743–750.
187. Hawman, D.W.; Stoermer, K.A.; Montgomery, S.A.; Pal, P.; Oko, L.; Diamond, M.S.; Morrison, T.E. Chronic Joint Disease Caused by Persistent Chikungunya Virus Infection is Controlled by the Adaptive Immune Response. J. Virol. 2013, 87, 13878–13888.
188. U.S. National Institutes of Health. Clinical Evaluation of Anti-CHIKV Hyperimmune Intravenous Immunoglobulins (CHIKVIVG-01). Available online: https://clinicaltri-als.gov/ ct2/show/NCT02230163?term=Chikungunya&rank=5 or http://www.webcita-tion.org/6YE7aebST (accessed on 2 May 2015).